ADX-626

N/A

Report date: 2025/07/24 20:00:11
NME

Base Information

Drug NameADX-626
Drug Alias NameADX-626
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionCoagulation factor XI inhibitors
TargetsCoagulation factor XI
Therapy Area/IndicationsThrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesADARx Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesADARx Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsThrombosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A